GlenRock Israel
Israelgrg.co.il
Overview
GlenRock Israel is a single-family office leveraging a combination of private equity funding agility, multidisciplinary in-house expertise, unmatched access to quality deal flow and a focused but flexible investment strategy to achieve maximum returns. The firm focuses on hand-picked solutions with viable business models that address real needs in strong growth-potential markets, primarily investing in Life Sciences and advanced technology opportunities.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MSICS Pharma | May 2026 | Seed | Lead |
| MSICS Pharma | Apr 2026 | Seed | Lead |
| Stargo | Mar 2025 | VC Round | Co-investor |
| Treetoscope | Sep 2023 | Seed | Co-investor |
| Hygieia Biological Laboratories | May 2023 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
